AIV Logo AIV Assistant

Loading...

 Logo IceCure Medical Ltd - ICCM Open IceCure Medical Ltd in new tab

0.71
EPS
-0.27
P/B
16.20
ROE
-2.31
Beta
2.47

0.7100

0.710

Daily: -4.93%
Key Metrics

Earnings date: Nov. 25, 2025

EPS: -0.27

Book Value: 0.05

Price to Book: 16.20

Debt/Equity: 81.98

% Insiders: 0.406%

Growth

Revenue Growth: -0.48%

Estimates

Forward P/E: -3.18

Forward EPS: -0.25

 Logo About IceCure Medical Ltd - (ICCM)

IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion